Dominic Tyer, Author at Pharmaphorum

Protected: Finding the roadmap for living with LHON

There is no excerpt because this is a protected post.

Protected: Finding the roadmap for living with LHON

https://pharmaphorum.com/disease-spotlight/finding-the-roadmap-living-with-lhon/

Parenting as a DMD patient

Parenting as a DMD patient The sleepless nights and steep learning curve that will be familiar to any

Parenting as a DMD patient

https://pharmaphorum.com/views-analysis-digital/parenting-as-a-dmd-patient/

The NHS and integrated care systems – how can pharma play its part?

The concept of joining up health and social care has been around a long time – but now

The NHS and integrated care systems – how can pharma play its part?

https://pharmaphorum.com/views-analysis-market-access/nhs-integrated-care-systems/

The changing face of pharmaceutical launches

The industry has experienced a sustained period of change since its blockbuster heyday in the 1990s and continues

The changing face of pharmaceutical launches

https://pharmaphorum.com/market-access-2/digital-transforming-pharmaceutical-launches/

FDA approves Janssen’s HIV combination Symtuza

Janssen has won US approval for its once-daily HIV pill Symtuza (D/C/F/TAF), which it hopes will improve patient

FDA approves Janssen’s HIV combination Symtuza

https://pharmaphorum.com/news/fda-janssen-hiv-symtuza/

Otsuka has high hopes for its ‘drug creation engine’ acquisition

Otsuka is paying $430 million for a US clinical-stage biotech company it hopes will act as a ‘drug

Otsuka has high hopes for its ‘drug creation engine’ acquisition

https://pharmaphorum.com/news/otsuka-biotech-visterra-hierotope/

Marketing science – brand innovation for pharma

Combining fields such as economics, statistics and operations research, marketing science has for some time operated under-the-radar as

Marketing science – brand innovation for pharma

https://pharmaphorum.com/debates-insight-sales-marketing/marketing-science-brand-innovation-for-pharma/

Was pharma bold enough at Lions Health 2018?

The Lions Health 2018 jury brought 10 senior communications executives together in Cannes, with representatives from China, Australia,

Was pharma bold enough at Lions Health 2018?

https://pharmaphorum.com/views-analysis-sales-marketing/pharma-bold-cannes-lions-health-2018/

He ain’t heavy – learning about a sibling’s DMD diagnosis

It’s common for patients to want to know more about what’s causing them to be ill and their

He ain’t heavy – learning about a sibling’s DMD diagnosis

https://pharmaphorum.com/views-and-analysis/learning-sibling-dmd-diagnosis/

Trending

About Dominic Tyer

Posts by Dominic Tyer:

Protected: Finding the roadmap for living with LHON

Parenting as a DMD patient

The NHS and integrated care systems – how can pharma play its part?

The changing face of pharmaceutical launches

FDA approves Janssen’s HIV combination Symtuza

Otsuka has high hopes for its ‘drug creation engine’ acquisition

Marketing science – brand innovation for pharma

Was pharma bold enough at Lions Health 2018?

He ain’t heavy – learning about a sibling’s DMD diagnosis

Search

Advanced Search

Trending

About Dominic Tyer

Posts by Dominic Tyer: